Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4841 - 4848 of 11616 results
Complying with the California Consumer Privacy Act: Are Health Care Organizations "Home Free"?
April 4, 2019| Blog| Viewpoint
Copyright Litigation Strategies
April 3, 2019| News
CMS’s New Part D Policies Address the Opioid Epidemic
April 3, 2019| Blog| Viewpoint
Blockchain in Energy: Stakeholders, Solutions and the Path to Standardization
April 3, 2019| Blog| Viewpoint
Time Is Quickly Running Out for First Quarter‘s IPO Hopefuls
April 2, 2019| News
Thorny Legal Questions and Answers in Net Lease
April 1, 2019| News
Changes to H-1B visa lottery create 'stress' for tech companies and employees
April 1, 2019| News
Energy & Sustainability Connections Newsletter – April 2019
April 1, 2019| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.